Highlights of prescribing information: Adderall XR. Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: A review for practitioners. Venlafaxine (Effexor).īrown KA, Samuel S, Patel DR. Journal of Child and Adolescent Psychopharmacology. A systematic review of the use of bupropion for attention-deficit/hyperactivity disorder in children and adolescents. Qelbree highlights of prescribing information. Attention deficit hyperactivity disorder (ADHD): Nonstimulant therapy (Strattera) & other ADHD drugs.įood and Drug Administration. Efficacy and tolerability of different interventions in children and adolescents with attention deficit hyperactivity disorder. Non-stimulant medications available for ADHD treatment. doi:10.1002/2Īmerican Academy of Pediatrics. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Otasowie J, Castells X, Ehimare UP, Smith CH. Tricyclic antidepressants for the treatment of ADHD in children and adolescents. Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: A review. The extended-release capsules comprise both immediate-release (IR) and extended-release beads such that 30 of the dose is provided by the IR component and 70 of the dose is provided by the ER component. Hutchison SL, Ghuman JK, Ghuman HS, Karpov I, Schuster JM. METADATE CD is a central nervous system (CNS) stimulant. Highlights of prescribing information: Strattera (amoxetine hydrochloride) capsules for oral use.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |